iCoreConnect Inc. (NASDAQ:ICCT – Get Free Report) was the target of a large drop in short interest in the month of January. As of January 15th, there was short interest totalling 42,400 shares, a drop of 61.6% from the December 31st total of 110,400 shares. Currently, 5.1% of the shares of the stock are sold short. Based on an average daily volume of 409,600 shares, the days-to-cover ratio is presently 0.1 days.
Insiders Place Their Bets
In other news, CEO Robert P. Mcdermott bought 11,839 shares of the firm’s stock in a transaction that occurred on Monday, November 25th. The shares were acquired at an average price of $3.60 per share, with a total value of $42,620.40. Following the acquisition, the chief executive officer now owns 61,494 shares of the company’s stock, valued at approximately $221,378.40. The trade was a 23.84 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through this link. 59.42% of the stock is owned by corporate insiders.
Hedge Funds Weigh In On iCoreConnect
An institutional investor recently bought a new position in iCoreConnect stock. Magnus Financial Group LLC purchased a new stake in shares of iCoreConnect Inc. (NASDAQ:ICCT – Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm purchased 25,010 shares of the company’s stock, valued at approximately $63,000. Magnus Financial Group LLC owned about 2.05% of iCoreConnect at the end of the most recent quarter. Hedge funds and other institutional investors own 13.42% of the company’s stock.
iCoreConnect Price Performance
iCoreConnect Company Profile
iCoreConnect Inc, a cloud-based software and technology company, provides Health Insurance Portability and Accountability Act (HIPAA) compliant cloud-based software as a service (SaaS) in the United States. The company’s products include iCoreRx, a HIPAA compliant electronic prescription software; iCorePDMP, a solution that checks the patient’s Prescription Drug Monitoring Program (PDMP) history before prescribing controlled substances; iCoreVerify and iCoreVerify+, a HIPAA compliant SaaS solution that automatically retrieves a patients insurance eligibility breakdown to verify their benefits in advance of their appointment and on-demand; iCoreHuddle and iCoreHuddle+, a tool to instantly reveal the revenue potential of each patient; and iCoreCodeGenius, a medical coding reference SaaS solution.
See Also
- Five stocks we like better than iCoreConnect
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- What Are Dividends? Buy the Best Dividend Stocks
- What Does the Future Hold for Eli Lilly?
- What is a Death Cross in Stocks?
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for iCoreConnect Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iCoreConnect and related companies with MarketBeat.com's FREE daily email newsletter.